Result card

  • CUR14: How much are intravenous immunoglobulins (IVIG) utilised currently and in the future?
English

How much are intravenous immunoglobulins (IVIG) utilised currently and in the future?

Authors: Antonio Migliore, Tapani Keranen, Sinikka Sihvo

Internal reviewers: Kristian Lampe

IVIG are currently used as first line therapy for various condition {90}. However, some new indications are emerging and extensions in the indications could be proposed {91}. At time of writing, no manufacturers have submitted requests to EMA for the market approval of the IVIG for Alzheimer’s disease including Mild Cognitive Impairment {Appendix CUR-3}.

Critical
Completely
Migliore A et al. Result Card CUR14 In: Migliore A et al. Health Problem and Current Use of the Technology In: Jefferson T, Cerbo M, Vicari N [eds.]. Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 24 October 2020]. Available from: http://corehta.info/ViewCover.aspx?id=267

References